Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012, Article ID 436710, 4 pages
http://dx.doi.org/10.1155/2012/436710
Research Article

In Vitro Investigation of a Terbinafine Impregnated Subcutaneous Implant for Veterinary Use

1Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine University of Tennessee, Knoxville, TN 37996, USA
2Melatek, LLC, 4738 Bergamot Way, Middleton, WI 53562, USA
3Seimens Molecular Imaging, 810 Innovation Drive, Knoxville, TN 37932, USA

Received 25 January 2012; Accepted 7 June 2012

Academic Editor: Jia You Fang

Copyright © 2012 M. J. Souza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. R. Thuesen, M. F. Bertelsen, L. Brimer, and M. T. Skaanild, “Selected pharmacokinetic parameters for Cefovecin in hens and green iguanas,” Journal of Veterinary Pharmacology and Therapeutics, vol. 32, no. 6, pp. 613–617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Glaser, J. Rice, J. Sheridan et al., “Stress-related immune suppression: health implications,” Brain Behavior and Immunity, vol. 1, no. 1, pp. 7–20, 1987. View at Google Scholar · View at Scopus
  3. C. G. Jiang, J. L. Morrow-Tesch, D. I. Beller, E. M. Levy, and P. H. Black, “Immunosuppression in mice induced by cold water stress,” Brain, Behavior, and Immunity, vol. 4, no. 4, pp. 278–291, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Zhang, K. Kishihara, B. Wang, K. Mizobe, C. Kubo, and K. Nomoto, “Restraint stress-induced immunosuppression by inhibiting leukocyte migration and Th1 cytokine expression during the intraperitoneal infection of Listeria monocytogenes,” Journal of Neuroimmunology, vol. 92, no. 1-2, pp. 139–151, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. W. F. Frick, J. F. Pollock, A. C. Hicks et al., “An emerging disease causes regional population collapse of a common North American bat species,” Science, vol. 329, no. 5992, pp. 679–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. S. Blehert, A. C. Hicks, M. Behr et al., “Bat white-nose syndrome: an emerging fungal pathogen?” Science, vol. 323, no. 5911, p. 227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Lorch, C. U. Meteyer, M. J. Behr et al., “Experimental infection of bats with Geomyces destructans causes white-nose syndrome,” Nature, vol. 480, pp. 376–378, 2011. View at Google Scholar
  8. U. Bechert, J. M. Christensen, R. Poppenga, H. Le, J. Wyatt, and T. Schmitt, “Pharmacokinetics of orally administered terbinafine in african penguins (spheniscus demersus) for potential treatment of aspergillosis,” Journal of Zoo and Wildlife Medicine, vol. 41, no. 2, pp. 263–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Bechert, J. M. Christensen, R. Poppenga, S. A. Fahmy, and P. Redig, “Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis),” Journal of Avian Medicine and Surgery, vol. 24, no. 2, pp. 122–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hosseini-Yeganeh and A. J. McLauchlan, “Tissue distribution of terbinafine in rats,” Journal of Pharmaceutical Sciences, vol. 90, no. 11, pp. 1817–1828, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Hosseini-Yeganeh and A. J. McLachlan, “Physiologically based pharmacokinetic model for terbinafine in rats and humans,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 7, pp. 2219–2228, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. K. A. Moriello, “Treatment of dermatophytosis in dogs and cats: review of published studies,” Veterinary Dermatology, vol. 15, no. 2, pp. 99–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Gianni, G. Caretta, and C. Romano, “Skin infection due to Geomyces pannorum var. Pannorum,” Mycoses, vol. 46, no. 9-10, pp. 430–432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Christen-Zaech, S. Patel, and A. J. Mancini, “Recurrent cutaneous Geomyces pannorum infection in three brothers with ichthyosis,” Journal of the American Academy of Dermatology, vol. 58, no. 5, supplement 1, pp. S112–S113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. G. Revankar, M. D. Nailor, and J. D. Sobel, “Use of terbinafine in rare and refractory mycoses,” Future Microbiology, vol. 3, no. 1, pp. 9–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Chaturvedi, S. S. Rajkumar, X. Li, G. J. Hurteau, M. Shtutman, and V. Chaturvedi, “Antifungal testing and high-throughput screening of compound library against geomyces destructans, the etiologic agent of geomycosis (WNS) in bats,” PLoS ONE, vol. 6, no. 3, Article ID e17032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Balfour and D. Faulds, “Terbinafine, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses,” Drugs, vol. 43, no. 2, pp. 259–284, 1992. View at Google Scholar · View at Scopus
  18. V. V. Villars and T. C. Jones, “Special features of the clinical use of oral terbinafine in the treatment of fungal diseases,” British Journal of Dermatology, Supplement, vol. 126, no. 39, pp. 61–69, 1992. View at Google Scholar · View at Scopus
  19. H. V. Carey, M. T. Andrews, and S. L. Martin, “Mammalian hibernation: cellular and molecular responses to depressed metabolism and low temperature,” Physiological Reviews, vol. 83, no. 4, pp. 1153–1181, 2003. View at Google Scholar · View at Scopus